Moloney Securities Asset Management LLC lessened its stake in shares of Genpact Limited (NYSE:G – Free Report) by 9.0% during the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 24,099 shares of the business services provider’s stock after selling 2,379 shares during the period. Moloney Securities Asset Management LLC’s holdings in Genpact were worth $1,061,000 as of its most recent filing with the SEC.
Several other institutional investors and hedge funds have also bought and sold shares of the stock. Asset Management One Co. Ltd. raised its holdings in Genpact by 149.5% during the second quarter. Asset Management One Co. Ltd. now owns 33,618 shares of the business services provider’s stock worth $1,480,000 after acquiring an additional 20,146 shares in the last quarter. First Citizens Bank & Trust Co. raised its holdings in Genpact by 259.2% during the second quarter. First Citizens Bank & Trust Co. now owns 19,365 shares of the business services provider’s stock worth $852,000 after acquiring an additional 13,974 shares in the last quarter. Ethic Inc. raised its holdings in Genpact by 30.9% during the second quarter. Ethic Inc. now owns 30,064 shares of the business services provider’s stock worth $1,309,000 after acquiring an additional 7,099 shares in the last quarter. Stephens Inc. AR raised its holdings in Genpact by 10.4% during the second quarter. Stephens Inc. AR now owns 71,587 shares of the business services provider’s stock worth $3,151,000 after acquiring an additional 6,761 shares in the last quarter. Finally, Chicago Partners Investment Group LLC raised its holdings in Genpact by 57.6% during the second quarter. Chicago Partners Investment Group LLC now owns 7,735 shares of the business services provider’s stock worth $355,000 after acquiring an additional 2,827 shares in the last quarter. Institutional investors own 96.03% of the company’s stock.
Genpact Price Performance
Genpact stock opened at $39.48 on Friday. Genpact Limited has a 12 month low of $37.82 and a 12 month high of $56.76. The stock’s 50 day moving average is $42.29 and its 200-day moving average is $43.95. The company has a current ratio of 1.53, a quick ratio of 1.53 and a debt-to-equity ratio of 0.32. The company has a market capitalization of $6.88 billion, a price-to-earnings ratio of 13.11, a PEG ratio of 1.37 and a beta of 0.89.
Genpact Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 23rd. Shareholders of record on Tuesday, December 9th will be paid a dividend of $0.17 per share. The ex-dividend date is Tuesday, December 9th. This represents a $0.68 annualized dividend and a yield of 1.7%. Genpact’s dividend payout ratio is presently 22.59%.
Analyst Ratings Changes
Several analysts recently issued reports on the company. Mizuho upped their target price on Genpact from $48.00 to $51.00 and gave the stock a “neutral” rating in a report on Tuesday, July 1st. JPMorgan Chase & Co. lowered their price target on Genpact from $55.00 to $50.00 and set a “neutral” rating on the stock in a research report on Wednesday, August 20th. Citigroup raised Genpact to a “hold” rating in a research report on Thursday. Deutsche Bank Aktiengesellschaft initiated coverage on Genpact in a research report on Thursday, July 17th. They set a “hold” rating and a $47.00 price target on the stock. Finally, Needham & Company LLC boosted their price target on Genpact from $50.00 to $53.00 and gave the stock a “buy” rating in a research report on Friday, August 8th. Three research analysts have rated the stock with a Buy rating and six have given a Hold rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $51.13.
Check Out Our Latest Report on G
Insider Buying and Selling at Genpact
In other Genpact news, CEO Balkrishan Kalra sold 55,000 shares of the company’s stock in a transaction on Thursday, September 11th. The stock was sold at an average price of $43.36, for a total transaction of $2,384,800.00. Following the completion of the sale, the chief executive officer directly owned 295,246 shares in the company, valued at $12,801,866.56. This represents a 15.70% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, SVP Piyush Mehta sold 76,902 shares of the stock in a transaction on Friday, September 12th. The shares were sold at an average price of $42.58, for a total value of $3,274,487.16. Following the completion of the transaction, the senior vice president owned 134,880 shares of the company’s stock, valued at $5,743,190.40. The trade was a 36.31% decrease in their ownership of the stock. The disclosure for this sale can be found here. 3.07% of the stock is owned by corporate insiders.
Genpact Profile
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.
Recommended Stories
- Five stocks we like better than Genpact
- Trading Halts Explained
- MarketBeat Week in Review – 10/20 – 10/24
- Stock Sentiment Analysis: How it Works
- Rayonier-PotlatchDeltic Merger Signals Industry Upside
- What Are Dividend Champions? How to Invest in the Champions
- Hims & Hers Short Interest Nears All-Time High, Buy The Dip?
Want to see what other hedge funds are holding G? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Genpact Limited (NYSE:G – Free Report).
Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.
